Regulatory T cells (Treg) in rheumatoid arthritis

Joint Bone Spine

Volumn 76, Issue 1, 2009, Pages 10-14

  Boissier, Marie Christophe ^a,b,c   Assier, Eric ^a,b,c   Biton, Jérome ^a,b,c   Denys, Anne ^a,b,c   Falgarone, Géraldine ^a,b,c   Bessis, Natacha ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

Cell therapy; Cytokines; Immunomodulation; Regulatory T lymphocytes; Rheumatoid arthritis; T lymphocytes

Indexed keywords

CD134 ANTIGEN; CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CELL THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; ARTHRITIS, RHEUMATOID; CELL COUNT; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; OX40 LIGAND; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 58249136903     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.08.002     Document Type: Short Survey

References (32)

1. Gershon R.K., and Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18 (1970) 723-737
2. Berthelot J.M., and Maugars Y. Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses. Joint Bone Spine 71 (2004) 374-380
3. Vignali D.A., Collison L.W., and Workman C.J. How regulatory T cells work. Nat Rev Immunol 8 (2008) 523-532
4. Boissier M.C., Assier E., Falgarone G., et al. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 75 (2008) 373-375
5. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
6. Marson A., Kretschmer K., Frampton G.M., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445 (2007) 931-935
7. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
8. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
9. Collison L.W., Workman C.J., Kuo T.T., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007) 566-569
10. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160 (1998) 1212-1218
11. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
12. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
13. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105 (2005) 735-741
14. Crispin J.C., Martinez A., and Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21 (2003) 273-276
15. + regulatory T cells in patients with Kawasaki disease. J Pediatr 145 (2004) 385-390
16. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 48 (2003) 1452-1460
17. + regulatory T cells. Arthritis Rheum 52 (2005) 2212-2221
18. Nguyen L.T., Jacobs J., Mathis D., et al. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56 (2007) 509-520
19. +CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172 (2004) 6435-6443
20. +CD25 high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 45 (2006) 1210-1217
21. +) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50 (2004) 2775-2785
22. + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140 (2005) 360-367
23. Ehrenstein M.R., Evans J.G., Singh A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200 (2004) 277-285
24. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6 (2004) R335-R346
25. +CD25hi T-regulatory cells. Blood 108 (2006) 253-261
26. +CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 67 (2008) 984-990
27. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56 (2007) 732-742
28. +) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193 (2001) 1285-1294
29. + regulatory T cells. J Immunol 177 (2006) 3806-3813
30. Falgarone G., Duclos M., and Boissier M.C. TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice. Joint Bone Spine 74 (2007) 523-526
31. Tang Q., Henriksen K.J., Bi M., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 (2004) 1455-1465
32. Lin C.H., and Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 33 (2003) 626-638